Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

62462 1502285060HCLSReviewMexicoJuly2017.pdf
Energy Boardroom

Stymied by Meda, deal-hungry Mylan could jump on Stada or Mallinckrodt

30.04.2014 / Fierce Pharma

Pharma dealmakers are having a field day, but so far, Mylan has been standing on the sidelines, itching to jump into the game. As Bloomberg reports, the U.S.-based generics maker has been promising another deal this year to follow up on 2013's Agila Specialties buyout–but so far, no such luck.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: